Glenmark Pharmaceuticals today said its partner Elite Pharmaceuticals Inc has received approval from the US health regulator for generic opioid analgesic methadone hydrochloride tablets used for treatment of severe pain.
The abbreviated new drug application (ANDA) approval by the United States Food and Drug Administration (USFDA) is for the tablets in the strengths of 5 mg and 10 mg, Glenmark said in a statement.
Methadone can also be used for maintenance treatment of opioid addiction (heroin or other morphine-like drugs) in conjunction with appropriate social and medical services, Glenmark said.
Shares of Glenmark were today trading at Rs 592.15 per scrip on BSE, down 1.09 per cent from its previous close.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)